Format

Send to

Choose Destination
Cell. 2013 Oct 24;155(3):515-8. doi: 10.1016/j.cell.2013.09.030. Epub 2013 Oct 24.

Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design.

Author information

1
Department of Medicine (Clinical Pharmacology), Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: chendrix@jhmi.edu.

Abstract

HIV pre-exposure prophylaxis trials with antiretroviral drugs have been variably successful. Even trials demonstrating the best efficacy leave room for improvement. Pharmacological data illuminate several sources of outcome variability, especially the impact of poor adherence, which is critical to manage PrEP in the clinic and to develop the next generation of PrEP candidates.

PMID:
24243011
DOI:
10.1016/j.cell.2013.09.030
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center